Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caram

Showing results (191-200 of 392) with videos related to

Pageof 40
Sort By:
Cureus|April 6, 2026
Spontaneous Intracranial Hemorrhage in Liver Failure: A Case-Based Approach to Transplant Candidacy and CareRamona Nicolau Raducu, Eslam Fouda, Nicolas Caram, et al.
Cancer Medicine|December 31, 2024
The 340B Drug Pricing Program and Management of Advanced Prostate CancerKassem S Faraj, Samuel R Kaufman, Mary Oerline, et al.
Vox Sanguinis|November 18, 2024
Coagulation assay results at birth in preterm infants: A cohort study highlighting the relevance of local reference values for interpretationNina Houben, Suzanne Fustolo-Gunnink, Camila Caram-Deelder, et al.
JCO Oncology Practice|April 8, 2021
Understanding Active Surveillance for Prostate CancerLillian Y Lai, Vahakn B Shahinian, Mary K Oerline, et al.
Chemical Communications (Cambridge, England)|January 3, 2024
Deuteration of heptamethine cyanine dyes enhances their emission efficacyHana Janeková, Hannah C Friedman, Marina Russo, et al.
Journal of the National Cancer Institute|July 25, 2024
Adverse events in men with advanced prostate cancer treated with androgen biosynthesis inhibitors and androgen receptor inhibitorsKassem S Faraj, Mary Oerline, Samuel R Kaufman, et al.
Cancer Medicine|July 21, 2023
Health care delivery system contributions to management of newly diagnosed prostate cancerNoah Krampe, Samuel R Kaufman, Mary K Oerline, et al.
Physical Chemistry Chemical Physics : PCCP|December 16, 2020
Surface chemical trapping of optical cycling centersHan Guo, Claire E Dickerson, Ashley J Shin, et al.
Journal of the National Cancer Institute|April 13, 2022
Risk of Metabolic and Cardiovascular Adverse Events With Abiraterone or Enzalutamide Among Men With Advanced Prostate CancerLillian Y Lai, Mary K Oerline, Megan E V Caram, et al.
JNCI Cancer Spectrum|August 29, 2023
In-office dispensing of oral targeted agents by urology practices in men with advanced prostate cancerDawson Hill, Samuel R Kaufman, Mary K Oerline, et al.
Pageof 40

Showing results (191-200 of 392) with videos related to

Sort By:
Pageof 40
Cureus|April 6, 2026
Spontaneous Intracranial Hemorrhage in Liver Failure: A Case-Based Approach to Transplant Candidacy and CareRamona Nicolau Raducu, Eslam Fouda, Nicolas Caram, et al.
Cancer Medicine|December 31, 2024
The 340B Drug Pricing Program and Management of Advanced Prostate CancerKassem S Faraj, Samuel R Kaufman, Mary Oerline, et al.
Vox Sanguinis|November 18, 2024
Coagulation assay results at birth in preterm infants: A cohort study highlighting the relevance of local reference values for interpretationNina Houben, Suzanne Fustolo-Gunnink, Camila Caram-Deelder, et al.
JCO Oncology Practice|April 8, 2021
Understanding Active Surveillance for Prostate CancerLillian Y Lai, Vahakn B Shahinian, Mary K Oerline, et al.
Chemical Communications (Cambridge, England)|January 3, 2024
Deuteration of heptamethine cyanine dyes enhances their emission efficacyHana Janeková, Hannah C Friedman, Marina Russo, et al.
Journal of the National Cancer Institute|July 25, 2024
Adverse events in men with advanced prostate cancer treated with androgen biosynthesis inhibitors and androgen receptor inhibitorsKassem S Faraj, Mary Oerline, Samuel R Kaufman, et al.
Cancer Medicine|July 21, 2023
Health care delivery system contributions to management of newly diagnosed prostate cancerNoah Krampe, Samuel R Kaufman, Mary K Oerline, et al.
Physical Chemistry Chemical Physics : PCCP|December 16, 2020
Surface chemical trapping of optical cycling centersHan Guo, Claire E Dickerson, Ashley J Shin, et al.
Journal of the National Cancer Institute|April 13, 2022
Risk of Metabolic and Cardiovascular Adverse Events With Abiraterone or Enzalutamide Among Men With Advanced Prostate CancerLillian Y Lai, Mary K Oerline, Megan E V Caram, et al.
JNCI Cancer Spectrum|August 29, 2023
In-office dispensing of oral targeted agents by urology practices in men with advanced prostate cancerDawson Hill, Samuel R Kaufman, Mary K Oerline, et al.
Pageof 40